Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 59651-548

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 59651-548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (500 mg (100 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (750 mg (100 Tablet Bottle))

Package Label-principal Display Panel (750 mg (100 Tablet Bottle))
This text provides information about extended-release Metformin hydrochloride tablets containing 750 mg. It includes details on the distributor Aurobindo Pharma USA, Inc., the recommended storage conditions, dosage instructions, and other relevant information. The tablets are to be dispensed in a light-resistant container and stored at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The text also mentions the code for dosage information and the manufacturing location in India.*
FDA Label Image

Structure (Metformin Str1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.